Highlights from ASH 2018
As usual, ASH provided lots of exciting updates in the management of lymphoma. One particularly interesting study from which data was presented at ASH was the ECHELON-2 study, which compared BV+CHP vs CHOP for patients with peripheral T-cell lymphoma. In the video above, Dr Graham Collins (Oxford, UK), Dr Alison J. Moskowitz (New York, USA) and Professor Andrei Shustov (Seattle, USA) provide their highlights from the meeting.
Interview and article by Esther Drain.
